Page last updated: 2024-08-21

alpha-aminopyridine and Cancer-Associated Pain

alpha-aminopyridine has been researched along with Cancer-Associated Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aquilano, M; Cerbai, C; Desideri, I; Dominici, L; Livi, L; Marinko, T; Meattini, I; Orazem, M; Ratosa, I; Ribnikar, D; Scoccimarro, E; Steinacher, M	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Cancer-Associated Pain

Article	Year
Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer. Clinical breast cancer, 2020, Volume: 20, Issue:6 Topics: Adult; Aged; Aminopyridines; Benzimidazoles; Breast Neoplasms; Cancer Pain; Chemoradiotherapy; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Middle Aged; Molecular Targeted Therapy; Neoplasm Staging; Organs at Risk; Pain Measurement; Palliative Care; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Radiotherapy Dosage; Treatment Outcome	2020

Article

Year

Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer.

Clinical breast cancer, 2020, Volume: 20, Issue:6

Topics: Adult; Aged; Aminopyridines; Benzimidazoles; Breast Neoplasms; Cancer Pain; Chemoradiotherapy; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Middle Aged; Molecular Targeted Therapy; Neoplasm Staging; Organs at Risk; Pain Measurement; Palliative Care; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Radiotherapy Dosage; Treatment Outcome

2020